| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/20/2002 | EP1011674B1 Transdermal therapeutic system containing the active substance scopolamine base |
| 03/20/2002 | EP0986568B1 Novel class of nucleic acid cationic transfecting agents |
| 03/20/2002 | EP0830129B1 Solid compositions containing polyethyleneoxide and a non-amorphous active principle |
| 03/20/2002 | EP0786986B1 Use of an unsaturated fatty alcohol |
| 03/20/2002 | EP0785796B1 A pharmaceutical formulation comprising a growth hormone and isoleucine |
| 03/20/2002 | EP0591385B1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 03/20/2002 | EP0564586B1 Aqueous vaginal douche and related methods |
| 03/20/2002 | CN2482411Y Gulingtie plaster |
| 03/20/2002 | CN1341029A Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomas |
| 03/20/2002 | CN1341022A Pharmaceutical composition containing porton pump inhibitors |
| 03/20/2002 | CN1341017A Combinations of formoterol and mometasone furoate for sathma |
| 03/20/2002 | CN1341016A Effervescent laxatives |
| 03/20/2002 | CN1341015A Sheet-form adhesive preparation |
| 03/20/2002 | CN1341014A Pharmaceutical capsule compositions containing loratadine and pseudoephedrine |
| 03/20/2002 | CN1341013A Method of preparing particles for agglomeration |
| 03/20/2002 | CN1340361A Process for preparing xenomal or autogenous tumor vaccine of liposome |
| 03/20/2002 | CN1340352A Quick-acting powdered medicine for treating stomatopathy |
| 03/20/2002 | CN1340344A Prescription of 'strong heart first-aid dropping pill' and its preparing process |
| 03/20/2002 | CN1340343A Process for preparing buccal lozenge of low-hygroscopicity freeze-dried royal jelly powder |
| 03/20/2002 | CN1340341A Thiaminogen injection and its preparing process |
| 03/20/2002 | CN1340310A Solid preparation with multi-core texture |
| 03/20/2002 | CN1081065C Compound oral liquid of cactus |
| 03/20/2002 | CN1081062C Brain nutritious oral liquor and its preparation |
| 03/20/2002 | CN1081061C Medicinal pill for treating piles |
| 03/20/2002 | CN1081060C Ointment for curing skin ulcer |
| 03/20/2002 | CN1081056C Anticarcinogen injection and its preparing process |
| 03/20/2002 | CN1081051C Blood stasis removing analgesic plaster and its preparation |
| 03/20/2002 | CN1081048C Method for preparing burn plaster |
| 03/20/2002 | CN1081037C Azithromycin suppository and ointment |
| 03/20/2002 | CN1081034C Medicine of diguanidino-prine-hydride compounds for giving up drug-taking |
| 03/20/2002 | CN1081032C Medicinal preparation containing saccharin zinc |
| 03/20/2002 | CN1081031C Calcium tablet |
| 03/20/2002 | CN1081030C External preparation containing tranilast and process for producing the same |
| 03/20/2002 | CN1081029C Sustained-release metal valproate tablets |
| 03/20/2002 | CN1081028C Patch for external use |
| 03/20/2002 | CN1081021C Medicine deltoid belt for hernia |
| 03/19/2002 | US6359191 Cylinder carrier; lactobacillus enclosed between layers |
| 03/19/2002 | US6359054 For gene therapy |
| 03/19/2002 | US6359016 Topical suspension formulations containing ciprofloxacin and dexamethasone |
| 03/19/2002 | US6359011 Denaturants for sympathomimetic amine salts |
| 03/19/2002 | US6359006 Antiischemic agents; anticancer agents |
| 03/19/2002 | US6359003 Fumaric acid alkyl esters for suppressing host versus graft reaction |
| 03/19/2002 | US6358989 Therapeutic inhibitor of vascular smooth muscle cells |
| 03/19/2002 | US6358939 Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
| 03/19/2002 | US6358935 Preserved cyclodextrin-containing compositions |
| 03/19/2002 | US6358929 Use of a peptide preventing the intolerance reactions of the skin, in particular in cosmetic compositions |
| 03/19/2002 | US6358732 Nucleotide sequences preferential polypeptides for use in the treatment of defects in central nervous system |
| 03/19/2002 | US6358727 Nucleotide sequences coding binding protein for use in treatment and prevention of infections |
| 03/19/2002 | US6358556 Drug release stent coating |
| 03/19/2002 | US6358539 To supplement collagen and elastic tissues and thicken the dermis to reduce or eliminate the appearance of cellulite |
| 03/19/2002 | US6358536 Nitric oxide donor compositions, methods, apparatus, and kits for preventing or alleviating vasoconstriction or vasospasm in a mammal |
| 03/19/2002 | US6358533 Pharmaceutical excipient having improved compressibility |
| 03/19/2002 | US6358532 Hollow microbeads |
| 03/19/2002 | US6358531 Method for preparing porous shells or gels from glass particles |
| 03/19/2002 | US6358530 Powdered pharmaceutical formulations having improved dispersibility |
| 03/19/2002 | US6358528 Pharmaceutical formulation |
| 03/19/2002 | US6358527 Administering tablet comprising galanthamine hydrobromide, carrier comprising lactose monohydrate, microcrystalline cellulose and polymer disintegrant for therapy of dementia, mania or nicotine dependence |
| 03/19/2002 | US6358526 Forming a compactable granular mixture comprising compaction enhancing therapeutic compound that is different from compaction enhancing therapeutic compound and non-aesthetic excipients; compressing the granular mixture to form tablets |
| 03/19/2002 | US6358525 Will release a therapeutic agent for a prolonged or sustained period of time |
| 03/19/2002 | US6358523 Macromolecule-lipid complexes and methods for making and regulating |
| 03/19/2002 | US6358522 For reducing anal leakage of oil in a patient to whom orlistat is being administered |
| 03/19/2002 | US6358518 Composition in the form of an O/W emulsion with a high wax content, and uses thereof in cosmetics and dermatology |
| 03/19/2002 | US6358514 Combination of a retinoid with a histidine derivative |
| 03/19/2002 | US6358504 Compounds and compositions for delivering active agents |
| 03/19/2002 | US6358443 Directing microdroplets into freezing section containing a liquefied gas; contacting frozen microdroplets in extraction section with liquid non-solvent to extract solvent into non-solvent to form microparticles |
| 03/19/2002 | US6358247 Cardiac drug delivery system |
| 03/19/2002 | US6358239 Platen pump |
| 03/19/2002 | US6358060 Two-stage transmucosal medicine delivery system for symptom relief |
| 03/19/2002 | CA2231886C Copolymeric micelle drug composition and method for the preparation thereof |
| 03/19/2002 | CA2187110C Benzamide derivative, compositions containing said derivative and use thereof |
| 03/19/2002 | CA2179019C Novel foaming compositions, particularly for rectal foams, and resulting foams |
| 03/19/2002 | CA2106975C Process for conditioning of water-soluble substances |
| 03/19/2002 | CA2105793C Process for producing compositions for ruminants |
| 03/19/2002 | CA2078885C Pharmaceutical compositions containing amethocaine |
| 03/19/2002 | CA2067733C Process for the preparation of a tablet or dragee composition containing a heat-, light- and moisture-sensitive active ingredient having monoclinic crystal structure |
| 03/19/2002 | CA2058835C Stable pharmaceutical composition and method for its production |
| 03/19/2002 | CA2034569C Oral pharmaceutical forms of pimobendan |
| 03/18/2002 | CA2319928A1 Apoptosis-mimicking synthetic entities and use thereof in medical treatments |
| 03/14/2002 | WO2002021141A2 Methods and compositions for diseases associated with amyloidosis |
| 03/14/2002 | WO2002020873A2 Method for precipitating mono and multiple layers of organophosphoric and organophosphonic acids and the salts thereof in addition to use thereof |
| 03/14/2002 | WO2002020649A1 Composition for soluble films with a new hydrolyzed polysaccharide |
| 03/14/2002 | WO2002020624A1 Controlled-release pharmaceuticals prepared by supercritical fluid processing techniques |
| 03/14/2002 | WO2002020619A2 HUMAN ANTIBODIES AGAINST PSEUDOMONAS AERUGINOSA LPS DERIVED FROM TRANSGENIC XENOMOUSE$m(3) |
| 03/14/2002 | WO2002020555A2 Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components |
| 03/14/2002 | WO2002020554A2 Hiv peptides from conserved regions in gag p17 and 924 and their application in e.g. vaccines |
| 03/14/2002 | WO2002020540A1 Adenosine derivatives and use thereof |
| 03/14/2002 | WO2002020539A1 Adenosine derivatives and use thereof |
| 03/14/2002 | WO2002020510A1 Acid-sensitive compounds, preparation and uses thereof |
| 03/14/2002 | WO2002020486A2 Picolinic acid derivatives for the prevention and treatment of cancer in animals |
| 03/14/2002 | WO2002020457A1 Dihydroxy open-acid salt of simvastatin |
| 03/14/2002 | WO2002020148A1 Transparent active substance capsules |
| 03/14/2002 | WO2002020090A2 Pharmaceutical compositions |
| 03/14/2002 | WO2002020088A1 Method and system for myocardial infarction repair |
| 03/14/2002 | WO2002020073A2 Devices, systems and methods for patient infusion |
| 03/14/2002 | WO2002020058A1 Preparations for oral administration |
| 03/14/2002 | WO2002020057A2 Flavoring systems for pharmaceutical compositions and methods of making such compositions |
| 03/14/2002 | WO2002020056A2 Methods and compositions for producing a neurosalutary effect in a subject |
| 03/14/2002 | WO2002020052A1 Use of lipopeptides for immunotherapy of hiv-positive subjects |
| 03/14/2002 | WO2002020042A1 A method for inducing immunity comprising phagocytic particles and atp receptors |
| 03/14/2002 | WO2002020040A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same |